N-4-tert-butyl benzyl haloperidol chloride suppresses ca 2+ -dependent egr-1 expression and subsequently inhibits vascular smooth muscle cell proliferation induced by angiotensin II

Cellular Physiology and Biochemistry

Volumn 23, Issue 4-6, 2009, Pages 295-304

  Chen, Yicun ^a   Zheng, Jinhong ^a   Zhang, Yanmei ^a   Wang, Jinzhi ^a   Liu, Qing ^a   Huang, Zhanqin ^a   Gao, Fenfei ^a   Zhou, Yanqiong ^a   Shi, Ganggang ^a,b  

^a SHANTOU UNIVERSITY   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Calcium; Early growth response gene (Egr 1); Platelet derived growth factor (PDGF); Vascular smooth muscle cell

Indexed keywords

ANGIOTENSIN II; CALCIUM ANTAGONIST; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; EARLY GROWTH RESPONSE FACTOR 1; EGTAZIC ACID; N 4 TERT BUTYL BENZYL HALOPERIDOL CHLORIDE; OLIGODEOXYRIBONUCLEOTIDE; PLATELET DERIVED GROWTH FACTOR A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 66749124747     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218176     Document Type: Article

References (43)

1. Intengan HP, Schiffrin EL: Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38:581-587.
2. Owens GK, Kumar MS, Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801.
3. Hao H, Gabbiani G, Bochaton-Piallat ML: Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 2003;23:1510-1520.
4. Bicknell KA, Brooks G: Reprogramming the cell cycle machinery to treat cardiovascular disease. Curr Opin Pharmacol 2008;8:193-201.
5. Berridge MJ, Bootman MD, Lipp P: Calcium-a life and death signal. Nature 1998;395:645-648.
6. Munaron L, Antoniotti S, Lovisolo D: Intracellular calcium signals and control of cell proliferation: how many mechanisms? J Cell Mol Med 2004;8:161-168.
7. Rothman A, Wolner B, Button D,Taylor P : Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary arterial smooth muscle cells. J Biol Chem 1994;269:6399-6404.
8. Kaufmann K, Thiel G: Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator. J Cell Biochem 2002;85:381-391.
9. Khachigian LM, Lindner V, Williams AJ, Collins T: Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 1996;271:1427-1431.
10. Silverman ES, Khachigian LM, Lindner V, Williams AJ, Collins T: Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr- 1 displacement of Sp1 and Sp3. Am J Physiol 1997;273:H1415-426.
11. Guillemot L, Levy A, Raymondjean M, Rothhut B: Angiotensin II- induced transcriptional activation of the cyclin D1 gene is mediated by Egr- 1 in CHOAT (1A) cells. J Biol Chem 2001;276:39394-39403.
12. Guadagno TM, Newport JW: Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell 1996;84:73-82.
13. Ragione FD, Cucciolla V, Criniti V, Indaco S, Borriello A, Zappia V: P21Cip1 gene expression is modulated by Egr1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect. The Journal of Biological Chemistry 2003;278:23360-23368.
14. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
15. 2+ source-dependent transcription of CRE-containing genes in vascular smooth muscle. Am J Physiol Heart Circ Physiol 2006;291:H97-105.
16. Goetze S, Xi XP, Graf K, Fleck E, Hsueh WA, Law RE: Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells. Febs Lett 1999;452:277-282.
17. Khachigian LM, Collins T: Inducible expression of Egr-1- dependent genes.A paradigm of transcriptional activation in vascular endothelium. Circ Res 1997;81:457-461.
18. Levon M. Khachigian: Early Growth response-1 in cardiovascular pathobiology. Circ Res 2006;98;186-191.
19. 2+ Response amplitude and duration. Nature 1997;386:855-858.
20. 2+ -permeable non-selective cation channels in smooth muscle cells. Cell Calcium 2003;33:345-356.
21. 2+ entry in A7r5 cells. Biochem J. 2005;389:821-829.
22. Yanmei Zhang, Ganggang Shi, Jinhong Zheng, Zhao Tang: The protective effects of N-n-butyl haloperidolIodide on myocardial ischemia-reperfusion injury in rats by inhibiting Egr-1 overexpression. Cell Physiol Biochem 2007;20:639-648.
23. Zhang YM, Shi GG, Tang Z, Zheng JH, Li WQ, Guo FX, Jia QY: Effects of N-n-butyl haloperidol iodide on myocardial ischemia/reperfusion injury and Egr-1 expression in rat. Acta Biochim Biophys Sin 2006;38:435-441.
24. Huang Z, Shi G, Gao F, Zhang Y, Liu X, Christopher TA, Lopez B, Ma X: Effect of N-n- butyl haloperidol iodide on L-type calcium channels and intracellular free calcium in rat ventricular myocytes. Biochem Cell Biol 2007;85:182-188.
25. Campbell JH, Kocher O, Skalli O, Gabbiani G, Campbell GR: Cytodifferentiation and expression of alpha-smooth muscle action mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. Arteriosclerosis 1989;9:633-643.
26. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME: A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
27. Sugawara F, Ninomiya H, Okamoto Y, Miwa S, Mazda O, Katsura Y, Masaki T: Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway. Mol Pharmacol 1996;49:447-457.
28. Roz L, Gramegna M, Ishii H, Croce CM, Sozzi G: Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci U S A 2002;99:3615-3620.
29. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
30. Berridge MJ: Calcium signaling and cell proliferation. BioEssays 1995;17:491-500.
31. Ryder N M, Guha S, Hines O J, Reber H A, Rozengurt E: G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation. J Cell Physiol 2001;186:53-64.
32. 2+ and proliferation in mesothelial cells. Eur J Pharmacol 2000;388:21-27.
33. 2+ Entry: A Way to Control Cell Proliferation. Curr Med Chem 2004;11:1533-1543.
34. Heeneman S, Sluimer JC, Daemen MJ: Angiotensin-Converting Enzyme and Vascular Remodeling. Circ. Res 2007;101;441-454.
35. Touyz, RM., Schiffrin: Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000;52:639-672.
36. Orlov S, Resink TJ, Bernhardt J, Ferracin F, Buhler FR: Vascular smooth muscle cell calcium fluxes: regulation by angiotensin II and lipoproteins. Hypertension 1993;21:195-203.
37. Arnaudeau S, Macrez-Lepretre N, Mironneau: Activation of calcium sparks by angiotensin II in vascular myocytes. Biochem. Biophys. Res Commun 1996;222,809-815.
38. 2+ channel blockers on human epidermoid carcinoma A431 cells. Eur J Pharmacol 2003;472:23-31.
39. 0 Enfissi A, Prigent S, Colosetti P, Capiod T: The blocking of capacitative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells. Cell Calcium 2004;36:459-467.
40. Hoth M, Button DC, Lewis RS: Mitochondrial control of calcium-channel gating: a mechanism for sustained signaling and transcriptional activation in T lymphocytes. Proc. Natl Acad Sci U S A 2000;97:10607-10612.
41. Holmuhamedov E, Lewis L, Bienengraeber M, Holmuhamedova M, Jahangir A, Terzic A: Suppression of human tumor cell proliferation through mitochondrial targeting. FASEB J 2002;16:1010-1016.
42. Haas TL, Stitelman D, Davis SJ, Apte SS, Madri JA: Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J Biol Chem 1999;274:22679-22685.
43. Santiago FS, Lowe HC, Kavurma MM, Chesterman CN, Baker A, Atkins D G, Kachigian LM: New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med 1999;5:1264-1269.